Top Story

FDA grants priority review to belantamab mafodotin for relapsed, refractory multiple myeloma

January 21, 2020

Physicians join John Theurer Cancer Center medical staff

January 18, 2020
John Theurer Cancer Center at Hacksensack University Cancer Center announced the appointment of five physicians to its medical staff.
Trend Watch

Cytovia partners with UCSF, New York Stem Cell Foundation to develop novel CAR-NK cell therapies

January 17, 2020
Cytovia Therapeutics announced research partnerships with both The New York Stem Cell Foundation Research Institute and University of California, San Francisco, for the…

Reflections on my 30th ASH Annual Meeting

HemOnc Today, January 10, 2020
John Sweetenham, MD
Since having the good fortune to take on an editorial role for HemOnc Today, I have resisted the temptation to use the January editorial to provide a summary of…
More Headlines »

2019 Texas Oncology Clinical Educational Symposium

This activity is supported by educational grants from AbbVie, Inc.; Celgene Corporation; Novartis Pharmaceuticals Corporation; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.; Takeda Oncology; and Verastem, Inc..

More »
Meeting News Coverage

VIDEO: Physicians must wait for STAMINA data to ‘really play out’ for posttransplant myeloma treatment

December 29, 2016
More »

Picking a PI in MM: Asking & Answering the W5

Provided by Integrity Continuing Education, Inc.
Supported by an educational grant from Takeda Oncology.

More »